Summary
- Current Price
- As of today, HOWL price is $0.86, up +10.63% on
- Current Price All-Time High
- HOWL price is currently -96.40% below its historical high of $23.99 set on
- Market Cap
- HOWL current market cap is $42M, down -9.26% year-over-year
- PE Ratio
- HOWL PE ratio is unknown
- Revenue
- HOWL current annual revenue is $1.89M, down -90.55% year-over-year
- Next Earnings
- As of today, the next earnings release for HOWL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Werewolf Therapeutics, Inc. |
| Ticker | NASDAQ: HOWL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | werewolftx.com |
| Employees | 46 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.86 | ||
| Price, 1D Change | +10.63% | |
| $42M | ||
| - | ||
| - | ||
| 2.05 | ||
| $2M | ||
| Revenue, 1Y Change | -90.55% | |
| -$1.63 | ||
| EPS, 1Y Change | -55.82% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.63 | ||
| EPS Estimate | N/A | -$1.51 |
| EPS Est. Change | N/A | +7.76% |
| $1.89M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.86 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +711.03% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.15 | -$1.05 | +8.84% | |
| -$1.42 | -$1.63 | -15.30% | |
| -$1.51 | N/A | +7.76% | |
| -$1.26 | N/A | +22.87% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $20.38M | $19.94M | -2.14% | |
| $1.88M | $1.89M | +0.27% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -16.20% | ||
| -64.48% | ||
| -9.26% | ||
| -51.13% | ||
| -90.55% | ||
| +100.00% | ||
| -55.82% | ||
| +77.90% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.86 | ||
| $1.11 | ||
| SMA 200 vs Price | +28.48% | |
| $0.69 | ||
| SMA 50 vs Price | -20.23% | |
| 2.05 | ||
| $0.07 | ||
| 62.01 | ||
| 93.28% | ||
| 101.80% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.89M | ||
| -$1.63 | ||
| $71.00K | ||
| 3.77% | ||
| -$73.59M | ||
| -3,904.19% | ||
| -$70.52M | ||
| -3,740.85% | ||
| -$64.05M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.51 | ||
| 7.45 | ||
| 7.45 | ||
| - | ||
| - | ||
| -4.79 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.41 | ||
| -0.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $73.39M | ||
| $111.00M | ||
| $129.50M | ||
| $113.07M | ||
| $56.11M | ||
| $15.18M | ||
| $37.09M | ||
| $1.56M | ||
| $3.04M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $75.48M | ||
| $75.48M | ||
| $1.81M | ||
| $19.05M | ||
| $1.81M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$56.19M | ||
| -$254.00K | ||
| $13.08M | ||
| $254.00K | ||
| -$56.44M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| B of A Securities | → | |
| JMP Securities | → | |
| Wedbush | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with HOWL
FAQ
What is the ticker symbol for Werewolf Therapeutics, Inc.?
The ticker symbol for Werewolf Therapeutics, Inc. is NASDAQ:HOWL
Does Werewolf Therapeutics, Inc. pay dividends?
No, Werewolf Therapeutics, Inc. does not pay dividends
What sector is Werewolf Therapeutics, Inc. in?
Werewolf Therapeutics, Inc. is in the Healthcare sector
What industry is Werewolf Therapeutics, Inc. in?
Werewolf Therapeutics, Inc. is in the Biotechnology industry
What country is Werewolf Therapeutics, Inc. based in?
Werewolf Therapeutics, Inc. is headquartered in United States
When did Werewolf Therapeutics, Inc. go public?
Werewolf Therapeutics, Inc. initial public offering (IPO) was on April 30, 2021
Is Werewolf Therapeutics, Inc. in the S&P 500?
No, Werewolf Therapeutics, Inc. is not included in the S&P 500 index
Is Werewolf Therapeutics, Inc. in the NASDAQ 100?
No, Werewolf Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Werewolf Therapeutics, Inc. in the Dow Jones?
No, Werewolf Therapeutics, Inc. is not included in the Dow Jones index
When was Werewolf Therapeutics, Inc. last earnings report?
Werewolf Therapeutics, Inc.'s most recent earnings report was on March 24, 2026
When does Werewolf Therapeutics, Inc. report earnings?
The date for Werewolf Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- HOWL Official Website werewolftx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1785530/000178553025000031/0001785530-25-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1785530/000178553025000008/0001785530-25-000008-index.htm
- HOWL Profile on Yahoo Finance finance.yahoo.com/quote/HOWL
- HOWL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/howl
